vce-003 and Parkinson-Disease

vce-003 has been researched along with Parkinson-Disease* in 1 studies

Other Studies

1 other study(ies) available for vce-003 and Parkinson-Disease

Article	Year
Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson's disease using 6-hydroxydopamine-lesioned mice. Molecular and cellular neurosciences, 2021, Volume: 110 Topics: Animals; Antiparkinson Agents; Cannabinoids; Cell Line, Tumor; Humans; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; PPAR gamma; Quinones; Substantia Nigra	2021

Article

Year

Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson's disease using 6-hydroxydopamine-lesioned mice.

Molecular and cellular neurosciences, 2021, Volume: 110

Topics: Animals; Antiparkinson Agents; Cannabinoids; Cell Line, Tumor; Humans; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; PPAR gamma; Quinones; Substantia Nigra

2021